Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


FDA funding

This article was originally published in The Tan Sheet

Executive Summary

Eleven trade associations, including CRN and CHPA, signed letters sent to the chairmen and ranking minority members of the Senate and House Appropriations/Agriculture Subcommittees on March 2, asking the committees to support increased funding for FDA. "We have joined together as a coalition because we all agree that the FDA needs additional resources," the letter states. President Clinton's FY 2001 budget request for FDA would provide the agency with a 13.3% funding hike; with user fees, human drugs would receive $329.8 mil., while the foods program would be allocated $328.9 mil. (1"The Tan Sheet" Feb. 14, p. 11). Commissioner Jane Henney, MD, testified before the Senate subcommittee on March 7 (2see related story, p. 11)

You may also be interested in...

Supplement AE Monitoring System Would Receive $2.5 Mil. In 2001 Budget

The Clinton Administration's budget for FY 2001, released Feb. 7, would allocate $2.5 mil. to CFSAN for an adverse event monitoring system for dietary supplements.

People In Brief

Perrigo promotes in pricing, planning

In Brief

Combe sells most of its OTC brands





Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts